Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.95

-4.2%

2:30 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (2690)	1/26/2001 11:07:30 AM
From: Biomaven	Read Replies (2) of 52153

Miljenko, Did they commented what were death reasons? MI? no details given. Why is 80% reduction -> p=NS? Maybe because the incidence is so low to begin with? I don't think Reopro or Integrilin ever got a statistically significant reduction in just death (as opposed to combined death + serious MI) even though they had very big trials. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next